Bio-Connect

NBS1 antibody [1C3]

GTX70222
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
Product group Antibodies
TargetNBN
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    NBS1 antibody [1C3]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    1C3
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID4683
  • Target name
    NBN
  • Target description
    nibrin
  • Target synonyms
    AT-V1, AT-V2, ATV, NBS, NBS1, P95, hNbs1, nibrin, Nijmegen breakage syndrome 1 (nibrin), cell cycle regulatory protein p95, p95 protein of the MRE11/RAD50 complex
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDO60934
  • Protein Name
    Nibrin
  • Scientific Description
    Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Tomioka K, Miyamoto T, Akutsu SN, et al. NBS1 I171V variant underlies individual differences in chromosomal radiosensitivity within human populations. Sci Rep. 2021,11(1):19661. doi: 10.1038/s41598-021-98673-7
    Read this paper
  • Hollingworth R, Stewart GS, Grand RJ. Productive herpesvirus lytic replication in primary effusion lymphoma cells requires S-phase entry. J Gen Virol. 2020,101(8):873-883. doi: 10.1099/jgv.0.001444
    Read this paper
  • Qi F, Meng Q, Hayashi I, et al. FXR1 is a novel MRE11-binding partner and participates in oxidative stress responses. J Radiat Res. 2020,61(3):368-375. doi: 10.1093/jrr/rraa011
    Read this paper
  • Raghunandan M, Yeo JE, Walter R, et al. Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery. Hum Mol Genet. 2020,29(7):1083-1095. doi: 10.1093/hmg/ddz250
    Read this paper
  • Ly P, Brunner SF, Shoshani O, et al. Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements. Nat Genet. 2019,51(4):705-715. doi: 10.1038/s41588-019-0360-8
    Read this paper
  • Hollingworth R, Horniblow RD, Forrest C, et al. Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. J Virol. 2017,91(22). doi: 10.1128/JVI.00930-17
    Read this paper
  • Petroni M, Sardina F, Heil C, et al. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ. 2016,23(2):197-206. doi: 10.1038/cdd.2015.81
    Read this paper
  • Harten SK, Oey H, Bourke LM, et al. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers. BMC Biol. 2015,13:21. doi: 10.1186/s12915-015-0128-2
    Read this paper
  • Cesare AJ, Hayashi MT, Crabbe L, et al. The telomere deprotection response is functionally distinct from the genomic DNA damage response. Mol Cell. 2013,51(2):141-55. doi: 10.1016/j.molcel.2013.06.006
    Read this paper
  • Anderson VE, Walton MI, Eve PD, et al. CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors. Cancer Res. 2011,71(2):463-72. doi: 10.1158/0008-5472.CAN-10-1252
    Read this paper